» Articles » PMID: 16682417

Pregnane X Receptor is a Target of Farnesoid X Receptor

Overview
Journal J Biol Chem
Specialty Biochemistry
Date 2006 May 10
PMID 16682417
Citations 52
Authors
Affiliations
Soon will be listed here.
Abstract

The pregnane X receptor (PXR) is an essential component of the body's detoxification system. PXR is activated by a broad spectrum of xenobiotics and endobiotics, including bile acids and their precursors. Bile acids in high concentrations are toxic; therefore, their synthesis is tightly regulated by the farnesoid X receptor, and their catabolism involves several enzymes regulated by PXR. Here we demonstrate that the expression of PXR is regulated by farnesoid X receptor. Feeding mice with cholic acid or the synthetic farnesoid X receptor (FXR) agonist GW4064 resulted in a robust PXR induction. This effect was abolished in FXR knock-out mice. Long time bile acid treatment resulted in an increase of PXR target genes in wild type mice. A region containing four FXR binding sites (IR1) was identified in the mouse Pxr gene. This region was able to trigger an 8-fold induction after GW4064 treatment in transactivation studies. Deletion or mutation of single IR1 sites caused a weakened response. The importance of each individual IR1 element was assessed by cloning a triple or a single copy and was tested in transactivation studies. Two elements were able to trigger a strong response, one a moderate response, and one no response to GW4064 treatment. Mobility shift assays demonstrated that the two stronger responding elements were able to bind FXR protein. This result was confirmed by chromatin immunoprecipitation. These results strongly suggest that PXR is regulated by FXR. Bile acids activate FXR, which blocks synthesis of bile acids and also leads to the transcriptional activation of PXR, promoting breakdown of bile acids. The combination of the two mechanisms leads to an efficient protection of the liver against bile acid induced toxicity.

Citing Articles

Personalized Risk Assessment of Hepatic Fibrosis after Cholecystectomy in Metabolic-Associated Steatotic Liver Disease: A Machine Learning Approach.

Suarez M, Martinez R, Torres A, Ramon A, Blasco P, Mateo J J Clin Med. 2023; 12(20).

PMID: 37892625 PMC: 10607671. DOI: 10.3390/jcm12206489.


Interaction of pregnane X receptor with hypoxia-inducible factor-1 regulates chemoresistance of prostate cancer cells.

Wang J, Nie D Cancer Drug Resist. 2023; 6(2):378-389.

PMID: 37457130 PMC: 10344723. DOI: 10.20517/cdr.2023.14.


Bile acid-mediated signaling in cholestatic liver diseases.

Zeng J, Fan J, Zhou H Cell Biosci. 2023; 13(1):77.

PMID: 37120573 PMC: 10149012. DOI: 10.1186/s13578-023-01035-1.


RNA-seq transcriptome profiling of pigs' liver in response to diet with different sources of fatty acids.

Fanalli S, da Silva B, Gomes J, Durval M, de Almeida V, Moreira G Front Genet. 2023; 14:1053021.

PMID: 36816031 PMC: 9936315. DOI: 10.3389/fgene.2023.1053021.


Cooperative Interaction of Phenolic Acids and Flavonoids Contained in Activated Charcoal with Herb Extracts, Involving Cholesterol, Bile Acid, and FXR/PXR Activation in Broilers Fed with Mycotoxin-Containing Diets.

Zhang Y, Lin Z, Wang L, Guo X, Hao Z, Li Z Antioxidants (Basel). 2022; 11(11).

PMID: 36358572 PMC: 9686537. DOI: 10.3390/antiox11112200.